These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6480880)

  • 21. Acceleration of digoxin clearance by activated charcoal.
    Lalonde RL; Deshpande R; Hamilton PP; McLean WM; Greenway DC
    Clin Pharmacol Ther; 1985 Apr; 37(4):367-71. PubMed ID: 3978996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-interaction between nifedipine and digoxin.
    Pedersen KE; Madsen JL; Klitgaard NA; Kjoer K; Hvidt S
    Dan Med Bull; 1986 Apr; 33(2):109-10. PubMed ID: 3709238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The hemodynamic and pharmacokinetic interactions between chronic use of oral levosimendan and digoxin in patients with NYHA Classes II-III heart failure.
    Harjola VP; Oikarinen L; Toivonen L; Jurkko R; Puttonen J; Sarapohja T; Sundberg S; Nieminen MS
    Int J Clin Pharmacol Ther; 2008 Aug; 46(8):389-99. PubMed ID: 18793580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of digoxin: interpreting bioavailability.
    Sanchez N; Sheiner LB; Halkin H; Melmon KL
    Br Med J; 1973 Oct; 4(5885):132-4. PubMed ID: 4752307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose-independent pharmacokinetics of digoxin in humans.
    Ochs HR; Greenblatt DJ; Bodem G; Harmatz JS
    Am Heart J; 1978 Oct; 96(4):507-11. PubMed ID: 358815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Digoxin kinetics during furosemide administration.
    Malcolm AD; Leung FY; Fuchs JC; Duarte JE
    Clin Pharmacol Ther; 1977 May; 21(5):567-74. PubMed ID: 870271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of dose on bioavailability of oral digoxin.
    Ochs HR; Bodem G; Greenblatt DJ
    Eur J Clin Pharmacol; 1981 Jan; 19(1):53-5. PubMed ID: 7461024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic treatment with fluvoxamine, clovoxamine, and placebo: interaction with digoxin and effects on sleep and alertness.
    Ochs HR; Greenblatt DJ; Verburg-Ochs B; Labedski L
    J Clin Pharmacol; 1989 Jan; 29(1):91-5. PubMed ID: 2496149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of diprafenone on the pharmacokinetics of digoxin.
    Koytchev R; Alken RG; Mayer O
    Eur J Clin Pharmacol; 1996; 50(1-2):97-100. PubMed ID: 8739818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence of nonlinearity in digoxin pharmacokinetics.
    Wagner JG; Popat KD; Das SK; Sakmar E; Movahhed H
    J Pharmacokinet Biopharm; 1981 Apr; 9(2):147-66. PubMed ID: 7277206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of furosemide on serum clearance and renal excretion of digoxin.
    Tsutsumi E; Fujiki H; Takeda H; Fukushima H
    J Clin Pharmacol; 1979 Apr; 19(4):200-4. PubMed ID: 438354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physiologically based pharmacokinetic model for digoxin disposition in dogs and its preliminary application to humans.
    Harrison LI; Gibaldi M
    J Pharm Sci; 1977 Dec; 66(12):1679-83. PubMed ID: 925929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of the pharmacokinetic interaction between zileuton and digoxin in humans.
    Awni WM; Hussein Z; Cavanaugh JH; Granneman GR; Dubé LM
    Clin Pharmacokinet; 1995; 29 Suppl 2():92-7. PubMed ID: 8620677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of pharmacokinetic interaction between gemifloxacin and digoxin in healthy elderly volunteers.
    Vousden M; Allen A; Lewis A; Ehren N
    Chemotherapy; 1999; 45(6):485-90. PubMed ID: 10567779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum digoxin by radioimmunoassay.
    Hoeschen RJ; Proveda V
    Can Med Assoc J; 1971 Jul; 105(2):170-3. PubMed ID: 5104858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Absence of an effect of a single-dose deferasirox on the steady-state pharmacokinetics of digoxin.
    Sechaud R; Robeva A; Belleli R; Balez S
    Int J Clin Pharmacol Ther; 2008 Oct; 46(10):519-26. PubMed ID: 18826866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of telaprevir on the pharmacokinetics of midazolam and digoxin.
    Garg V; Chandorkar G; Farmer HF; Smith F; Alves K; van Heeswijk RP
    J Clin Pharmacol; 2012 Oct; 52(10):1566-73. PubMed ID: 22162542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum).
    Johne A; Brockmöller J; Bauer S; Maurer A; Langheinrich M; Roots I
    Clin Pharmacol Ther; 1999 Oct; 66(4):338-45. PubMed ID: 10546917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absorption of beta-methyl-digoxin determined after a single dose and under steady state conditions.
    Boerner D; Olcay A; Schaumann W; Weiss W
    Eur J Clin Pharmacol; 1976 Feb; 9(4):307-14. PubMed ID: 971714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The long-term effect of verapamil on plasma digoxin concentration and renal digoxin clearance in healthy subjects.
    Pedersen KE; Dorph-Pedersen A; Hvidt S; Klitgaard NA; Pedersen KK
    Eur J Clin Pharmacol; 1982; 22(2):123-7. PubMed ID: 7094982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.